MedTrace Logo

Total Hip Arthroplasty (THA) Lumbar Plexus Verses Periarticular

NCT02242201 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2018-04-19

Study results available
· View outcomes & findings →

Summary

Total hip arthroplasty is a one of the most commonly performed surgical procedures with increasing numbers anticipated over the next several decades. The purpose of this study was to find a better way to make patients comfortable after their hip surgery. Three different ways of providing pain relief were compared, a peripheral nerve block in the lower back outside of the spinal space (using bupivacaine, a numbing medicine), or injections around the hip joint with one of two different medicines, either Ropivacaine or Liposomal Bupivacaine (Exparel®).

Conditions

  • Total Hip Arthroplasty

Interventions

DRUG

PNB Bupivacaine

Infusion

DRUG

PAI Ropivacaine

Injection

DRUG

PAI liposomal bupivacaine

Injection

DRUG

Epinephrine

Injection, weight-based dosage of 100 mcg - 300 mcg

DRUG

Ketorolac

Injection, 30 mg

Sponsors & Collaborators

Principal Investigators

  • Rebecca Johnson, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-09-30
Completion
2016-09-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02242201 on ClinicalTrials.gov